Researchers have shown that a decrease in CDH1 expression is associated with astrocytoma progression [29,30], while other studies showed that high E-cadherin expression is associated with a poorer prognosis of the disease [31]. This evidence concerns the gene CDH1 and astrocytoma (excluding glioblastoma).